Equality and Human Rights consultation - NICE TA - Nintedanib for previously treated locally advanced, metastatic or locally recurrent non-small cell lung cancer
Consultation opened on 02 June 2015. Closing date 13 July 2015.
Summary
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1st July 2006, DHSSPS established links with NICE whereby all technology appraisals and clinical guidelines published from that date are locally reviewed for applicability to Northern Ireland and, where appropriate, are endorsed for implementation in health and social care. This link has ensured that Northern Ireland has access to up to date, independent, professional, evidence based guidance on the value of health care interventions.
Consultation description
Guidance for the consultation can be found on the NICE website.
The HSC (SQSD) 2/13 circular provides details of the process for the endorsement, implementation, monitoring and assurance of NICE Technology Appraisals in Northern Ireland.
In order to meet the timescales set out in the circular, the closing date for responses is Monday 13th July 2015.